Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
In clinical and wellness settings, BPC-157 therapy is provided as part of a provider-supervised treatment plan focused on recovery support, mobility, and overall physical function
The 2.4 mg maintenance dose is close to the 1 mL capacity of a standard U-100 insulin syringe, which is why some community sources reconstitute cagrilintide at higher concentration (e.g., 5 mg in 1.5 mL 3.33 mg/mL 2.4 mg = 0.72 mL = 72 units) to keep dose volume manageable
Evidence boundary No published clinical trial has tested BPC-157 + TB-500 together
Studies have shown [11]: Prevention of gastric lesions when co-administered with NSAIDs Healing of existing NSAID-induced damage Protection of both upper and lower GI tract Preservation of intestinal permeability This is particularly significant given that millions of people take NSAIDs regularly, often experiencing GI side effects
US$ 22.74
US$ 23.48
US$ 20.54
US$ 27.45
US$ 27.77
US$ 24.60
US$ 29.84
US$ 23.80
US$ 21.11
